Layer-by-layer self-assembly vectors for Gene Delivery

Current Gene Therapy

Volumn 11, Issue 1, 2011, Pages 58-73

  Li, Peng ^a   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Gene delivery; Layer by layer; Multilayered films; Polyelectrolyte; Self assembly vectors

Indexed keywords

DNA; POLYCATION; POLYELECTROLYTE; VIRUS VECTOR;

ARTICLE; CHEMICAL STRUCTURE; GENE TARGETING; GENE VECTOR; HUMAN; IONIC STRENGTH; NONVIRAL GENE DELIVERY SYSTEM; PH; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; NANOPARTICLES; NUCLEIC ACIDS; PARTICLE SIZE; POLYAMINES;

EID: 79951705174     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652311794520067     Document Type: Article

References (173)

1. Mavilio F. Gene therapy: back on track? EMBO Rep; 11: 75.
2. Sher YP, Tzeng TF, Kan SF, et al. Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves longtermsurvival. Oncogene 2009; 28: 3286-95.
3. Gould DJ, Chernajovsky Y. Novel delivery methods to achieveimmunomodulation. Curr Opin Pharmacol 2007; 7: 445-50.
4. Ott MG, Seger R, Stein S, et al. Advances in the treatment of Chronic Granulomatous Disease by gene therapy. Curr Gene Ther 2007; 7: 155-61.
5. Nikol S. Therapeutic angiogenesis for peripheral artery disease:gene therapy. Vasa 2007; 36: 165-73.
6. Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trialsworldwide to 2007--an update. J Gene Med 2007; 9: 833-42.
7. Hassan MH, Othman EE, Hornung D, et al. Gene therapy of benigngynecological diseases. Adv Drug Deliv Rev 2009; 61: 822-35.
8. Wolff JA, Rozema DB. Breaking the bonds: non-viral vectorsbecome chemically dynamic. Mol Ther 2008; 16: 8-15.
9. Romano G. Current development of adeno-associated viral vectors. Drug News Perspect 2005; 18: 311-6.
10. Srinivasan C, Burgess DJ. Optimization and characterization of anionic lipoplexes for gene delivery. J Control Release 2009; 136: 62-70.
11. Godbey WT, Mikos AG. Recent progress in gene delivery usingnon-viral transfer complexes. J Control Release 2001; 72: 115-25.
12. Kogure K, Akita H, Harashima H. Multifunctional envelope-typenano device for non-viral gene delivery: concept and application of Programmed Packaging. J Control Release 2007; 122: 246-51.
13. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol 2000; 18: 33-7.
14. Segura T, Shea LD. Surface-tethered DNA complexes for enhancedgene delivery. Bioconjug Chem 2002; 13: 621-9.
15. Sasaki K, Kogure K, Chaki S, et al. An artificial virus-like nanocarrier system: enhanced endosomal escape of nanoparticles viasynergistic action of pH-sensitive fusogenic peptide derivatives. Anal Bioanal Chem 2008; 391: 2717-27.
16. Bergen JM, Pun SH. Evaluation of an LC8-binding peptide for theattachment of artificial cargo to dynein. Mol Pharm 2007; 4: 119-28.
17. Cohen RN, Rashkin MJ, Wen X, et al. Molecular motors as drugdelivery vehicles. Drug Discov Today Tech 2005; 2: 111-8.
18. van der Aa MA, Mastrobattista E, Oosting RS, et al. The nuclearpore complex: the gateway to successful nonviral gene delivery. Pharm Res 2006; 23: 447-59.
19. Johansen P, Men Y, Merkle HP, et al. Revisiting PLA/PLGA microspheres:an analysis of their potential in parenteral vaccination. Eur J Pharm Biopharm 2000; 50: 129-46.
20. Walter E, Dreher D, Kok M, et al. Hydrophilic poly(DL-lactide-coglycolide)microspheres for the delivery of DNA to human-derivedmacrophages and dendritic cells. J Control Release 2001; 76: 149-68.
21. Wang C, Ge Q, Ting D, et al. Molecularly engineered poly(orthoester) microspheres for enhanced delivery of DNA vaccines. NatMater 2004; 3: 190-6.
22. Walter E, Moelling K, Pavlovic J, et al. Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and releasecharacteristics. J Control Release 1999; 61: 361-74.
23. Wang DQ, Robinson DR, Kwon GS, et al. Encapsulation of plasmidDNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheresas a novel approach for immunogene delivery. J ControlRelease 1999; 57: 9-18.
24. Diez S, Tros de Ilarduya C. Versatility of biodegradable poly(D, Llactic-co-glycolic acid) microspheres for plasmid DNA delivery. Eur J Pharm Biopharm 2006; 63: 188-97.
25. Kasturi SP, Sachaphibulkij K, Roy K. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. Biomaterials 2005; 26: 6375-85.
26. Oster CG, Kim N, Grode L, et al. Cationic microparticles consistingof poly(lactide-co-glycolide) and polyethylenimine as carrierssystems for parental DNA vaccination. J Control Release 2005; 104: 359-77.
27. Messai I, Lamalle D, Munier S, et al. Poly(D, L-lactic acid) and chitosan complexes: interactions with plasmid DNA. Colloids SurfA Physicochem Eng Asp 2005; 255: 65-72.
28. Munier S, Messai I, Delair T, et al. Cationic PLA nanoparticles forDNA delivery: comparison of three surface polycations for DNAbinding, protection and transfection properties. Colloids Surf BBiointerfaces 2005; 43: 163-73.
29. Reibetanz U, Claus C, Typlt E, et al. Defoliation and plasmid deliverywith layer-by-layer coated colloids. Macromol Biosci 2006; 6: 153-60.
30. Lynn DM. Layers of opportunity: nanostructured polymer assembliesfor the delivery of macromolecular therapeutics. Soft Matter 2006; 2: 269-73.
31. Lynn DM. Peeling back the layers: controlled erosion and triggereddisassembly of multilayered polyelectrolyte thin films. Adv Mater 2007; 19: 4118-30.
32. Decher G. Fuzzy Nanoassemblies: toward Layered PolymericMulticomposites. Science 1997; 277: 1232-7.
33. Sukhishvili SA. Responsive polymer films and capsules via layerby-layer assembly. Curr Opin Colloid Interface Sci 2005; 10: 37-44.
34. Tang ZY, Wang Y, Podsiadlo P, et al. Biomedical applications of layer-by-layer assembly: From biomimetics to tissue engineering. Adv Mater 2006; 18: 3203-24.
35. Inoue H, Sato K, Anzai J. Disintegration of layer-by-layer assembliescomposed of 2-iminobiotin-labeled poly(ethyleneimine) and avidin. Biomacromolecules 2005; 6: 27-9.
36. Sato K, Imoto Y, Sugama J, et al. Sugar-induced disintegration of layer-by-layer assemblies composed of concanavalin A and glycogen. Langmuir 2005; 21: 797-9.
37. Zeng G, Gao J, Chen S, et al. Combining hydrogen-bonding complexationin solution and hydrogen-bonding-directed layer-by-layerassembly for the controlled loading of a small organic moleculeinto multilayer films. Langmuir 2007; 23: 11631-6.
38. Ariga K, Hill JP, Ji QM. Layer-by-layer assembly as a versatilebottom-up nanofabrication technique for exploratory research and realistic application. Phys Chem Chem Phys 2007; 9: 2319-40.
39. Antipov AA, Sukhorukov GB. Polyelectrolyte multilayer capsulesas vehicles with tunable permeability. Adv Colloid Interface Sci 2004; 111: 49-61.
40. Blacklock J, You YZ, Zhou QH, et al. Gene delivery in vitro and invivo from bioreducible multilayered polyelectrolyte films of plasmidDNA. Biomaterials 2009; 30: 939-50.
41. Saurer EM, Jewell CM, Kuchenreuther JM, et al. Assembly of erodible, DNA-containing thin films on the surfaces of polymermicroparticles: toward a layer-by-layer approach to the delivery of DNA to antigen-presenting cells. Acta Biomater 2009; 5: 913-24.
42. Jessel N, Oulad-Abdelghani M, Meyer F, et al. Multiple and timescheduledin situ DNA delivery mediated by beta-cyclodextrin embeddedin a polyelectrolyte multilayer. Proc Natl Acad Sci U S A 2006; 103: 8618-21.
43. Zhang JT, Chua LS, Lynn DM. Multilayered thin films that sustainthe release of functional DNA under physiological conditions. Langmuir 2004; 20: 8015-21.
44. Peyratout CS, Dahne L. Tailor-made polyelectrolyte microcapsules:from multilayers to smart containers. Angew Chem Int EdEngl 2004; 43: 3762-83.
45. Hirsjarvi S, Peltonen L, Hirvonen J. Layer-by-layer polyelectrolytecoating of low molecular weight poly(lactic acid) nanoparticles. Colloids Surf B Biointerfaces 2006; 49: 93-9.
46. Voigt A, Lichtenfeld H, Sukhorukov GB, et al. Membrane filtrationfor microencapsulation and microcapsules fabrication by layerby-layer polyelectrolyte adsorption. Ind Eng Chem Res 1999; 38: 4037-43.
47. De Geest BG, Sanders NN, Sukhorukov GB, et al. Release mechanismsfor polyelectrolyte capsules. Chem Soc Rev 2007; 36: 636-49.
48. Mauser T, Dejugnat C, Mohwald H, et al. Microcapsules made of weak polyelectrolytes: Templating and stimuli-responsive properties. Langmuir 2006; 22: 5888-93.
49. De Geest BG, Jonas AM, Demeester J, et al. Glucose-responsivepolyelectrolyte capsules. Langmuir 2006; 22: 5070-4.
50. Rivera Gil P, del Mercato LL, del-Pino P, et al. Nanoparticlemodifiedpolyelectrolyte capsules. Nano Today 2008; 3: 12-21.
51. Dejugnat C, Halozan D, Sukhorukov GB. Defined picogram doseinclusion and release of macromolecules using polyelectrolyte microcapsules. Macromol Rapid Commun 2005; 26: 961-7.
52. De Geest BG, Dejugnat C, Prevot M, et al. Self-rupturing and hollow microcapsules prepared from bio-polyelectrolyte-coatedmicrogels. Adv Funct Mater 2007; 17: 531-7.
53. Schuler C, Caruso F. Decomposable hollow biopolymer-basedcapsules. Biomacromolecules 2001; 2: 921-6.
54. Vinogradova OI, Lebedeva OV, Vasilev K, et al. MultilayerDNA/poly(allylamine hydrochloride) microcapsules: assembly and mechanical properties. Biomacromolecules 2005; 6: 1495-502.
55. Luo D, Han E, Belcheva N, et al. A self-assembled, modular DNAdelivery system mediated by silica nanoparticles. J Control Release 2004; 95: 333-41.
56. Trubetskoy VS, Wong SC, Subbotin V, et al. Recharging cationicDNA complexes with highly '1charged polyanions for in vitro and in vivo gene delivery. Gene Ther 2003; 10: 261-71.
57. Kreft O, Georgieva R, Baumler H, et al. Red blood cell templatedpolyelectrolyte capsules: A novel vehicle for the stable encapsulationof DNA and proteins. Macromol Rapid Commun 2006; 27: 435-40.
58. Kakade S, Manickam DS, Handa H, et al. Transfection activity of layer-by-layer plasmid DNA/poly(ethylenimine) films deposited onPLGA microparticles. Int J Pharm 2009; 365: 44-52.
59. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: anemerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005; 113: 823-39.
60. Luten J, van Nostruin CF, De Smedt SC, et al. Biodegradablepolymers as non-viral carriers for plasmid DNA delivery. J ControlRelease 2008; 126: 97-110.
61. Zaitsev S, Cartier R, Vyborov O, et al. Polyelectrolyte nanoparticlesmediate vascular gene delivery. Pharm Res 2004; 21: 1656-61.
62. Saul JM, Wang CHK, Ng CP, et al. Multilayer nanocomplexes of polymer and DNA exhibit enhanced gene delivery. Adv Mater 2008; 20: 1091-1091.
63. Foged C, Brodin B, Frokjaer S, et al. Particle size and surfacecharge affect particle uptake by human dendritic cells in an in vitromodel. Int J Pharm 2005; 298: 315-22.
64. O'Hagan DT, Singh M, Ulmer JB. Microparticles for the deliveryof DNA vaccines. Immunol Rev 2004; 199: 191-200.
65. Jilek S, Merkle HP, Walter E. DNA-loaded biodegradable microparticlesas vaccine delivery systems and their interaction withdendritic cells. Adv Drug Deliv Rev 2005; 57: 377-90.
66. Reddy ST, Swartz MA, Hubbell JA. Targeting dendritic cells withbiomaterials: developing the next generation of vaccines. TrendsImmunol 2006; 27: 573-9.
67. Schatz C, Domard A, Viton C, et al. Versatile and efficient formationof colloids of biopolymer-based polyelectrolyte complexes. Biomacromolecules 2004; 5: 1882-92.
68. Angelatos AS, Katagiri K, Caruso F. Bioinspired colloidal systemsvia layer-by-layer assembly. Soft Matter 2006; 2: 18-23.
69. Sato H, Anzai J. Preparation of layer-by-layer thin films composedof DNA and ferrocene-bearing poly(amine)s and their redox properties. Biomacromolecules 2006; 7: 2072-6.
70. Ren K, Ji J, Shen J. Construction and enzymatic degradation of multilayered poly-l-lysine/DNA films. Biomater 2006; 27: 1152-9.
71. Wang ZJ, Qian L, Wang XL, et al. Construction of hollowDNA/PLL microcapsule as a dual carrier for controlled delivery of DNA and drug. Colloids Surf A Physicochem Eng Asp 2008; 326: 29-36.
72. Yuan W, Dong H, Li CM, et al. pH-controlled construction of chitosan/alginate multilayer film: characterization and applicationfor antibody immobilization. Langmuir 2007; 23: 13046-52.
73. Lin QK, Ren KF, Ji J. Hyaluronic acid and chitosan-DNA complexmultilayered thin film as surface-mediated nonviral gene deliverysystem. Colloid Surf B Biointerfaces 2009; 74: 298-303.
74. Godbey WT, Barry MA, Saggau P, et al. Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J BiomedMater Res 2000; 51: 321-8.
75. Morille M, Passirani C, Vonarbourg A, et al. Progress in developingcationic vectors for non-viral systemic gene therapy againstcancer. Biomaterials 2008; 29: 3477-96.
76. Akinc A, Thomas M, Klibanov AM, et al. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005; 7: 657-63.
77. Fischer D, Li Y, Ahlemeyer B, et al. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003; 24: 1121-31.
78. Gao X, Kim KS, Liu DX. Nonviral gene delivery: What we knowand what is next. Aaps J 2007; 9: E92-E104.
79. Fischer D, Bieber T, Li Y, et al. A novel non-viral vector for DNAdelivery based on low molecular weight, branched polyethylenimine:effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999; 16: 1273-9.
80. Lampela P, Soininen P, Urtti A, et al. Synergism in gene deliveryby small PEIs and three different nonviral vectors. Int J Pharm 2004; 270: 175-84.
81. Dong W, Jin GH, Li SF, et al. Cross-linked polyethylenimine aspotential DNA vector for gene delivery with high efficiency and low cytotoxicity. Acta Biochim Biophys Sin (Shanghai) 2006; 38: 780-7.
82. Thomas M, Ge Q, Lu JJ, et al. Cross-linked small polyethylenimines:While still nontoxic, deliver DNA efficiently to mammaliancells in vitro and in vivo. Pharm Res 2005; 22: 373-80.
83. Kim YH, Park JH, Lee M, et al. Polyethylenimine with acid-labilelinkages as a biodegradable gene carrier. J Control Release 2005; 103: 209-19.
84. Sung SJ, Min SH, Cho KY, et al. Effect of polyethylene glycol ongene delivery of polyethylenimine. Biol Pharm Bull 2003; 26: 492-500.
85. Kim WJ, Yockman JW, Lee M, et al. Soluble Flt-1 gene deliveryusing PEI-g-PEG-RGD conjugate for anti-angiogenesis. J ControlRelease 2005; 106: 224-34.
86. Jeong JH, Lee M, Kim WJ, et al. Anti-GAD antibody targeted nonviralgene delivery to islet beta cells. J Control Release 2005; 107: 562-70.
87. Hwa KS, Hoon JJ, Chul CK, et al. Target-specific gene silencingby siRNA plasmid DNA complexed with folate-modifiedpoly(ethylenimine). J Control Release 2005; 104: 223-32.
88. Lollo CP, Banaszczyk MG, Mullen PM, et al. Poly-L-lysine-basedgene delivery systems. Synthesis, purification, and application. Methods Mol Med 2002; 69: 1-13.
89. Kwoh DY, Coffin CC, Lollo CP, et al. Stabilization of poly-Llysine/DNA polyplexes for in vivo gene delivery to the liver. BiochimBiophys Acta 1999; 1444: 171-90.
90. Meyer M, Zintchenko A, Ogris M, et al. A dimethylmaleic acidmelittin-polylysine conjugate with reduced toxicity, pH-triggeredendosomolytic activity and enhanced gene transfer potential. JGene Med 2007; 9: 797-805.
91. Kaneshiro TL, Wang X, Lu ZR. Synthesis, characterization, and gene delivery of poly-L-lysine octa(3-aminopropyl)silsesquioxanedendrimers: nanoglobular drug carriers with precisely defined moleculararchitectures. Mol Pharm 2007; 4: 759-68.
92. Romoren K, Thu BJ, Evensen O. Immersion delivery of plasmidDNA. II. A study of the potentials of a chitosan based delivery systemin rainbow trout (Oncorhynchus mykiss) fry. J Control Release 2002; 85: 215-25.
93. Hejazi R, Amiji M. Chitosan-based gastrointestinal delivery systems. J Control Release 2003; 89: 151-65.
94. Lee M, Nah JW, Kwon Y, et al. Water-soluble and low molecularweight chitosan-based plasmid DNA delivery. Pharm Res 2001; 18: 427-31.
95. Tong HJ, Shi Q, Fernandes JC, et al. Progress and Prospects of chitosan and its derivatives as non-viral gene vectors in gene therapy. Curr Gene Ther 2009; 9: 495-502.
96. Ghosn B, Kasturi SP, Roy K. Enhancing polysaccharide-mediateddelivery of nucleic acids through functionalization with secondaryand tertiary amines. Curr Top Med Chem 2008; 8: 331-40.
97. Jin H, Xu CX, Kim HW, et al. Urocanic acid-modified chitosanmediatedPTEN delivery via aerosol suppressed lung tumorigenesisin K-rasLA1 mice. Cancer Gene Ther 2008; 15: 275-83.
98. Hashimoto M, Morimoto M, Saimoto H, et al. Lactosylated chitosanfor DNA delivery into hepatocytes: The effect of lactosylationon the physicochemical properties and intracellular trafficking of pDNA/chitosan complexes. Bioconjug Chem 2006; 17: 309-16.
99. Issa MM, Koping-Hoggard M, Tommeraas K, et al. Targeted genedelivery with trisaccharide-substituted chitosan oligomers in vitroand after lung administration in vivo. J Control Release 2006; 115: 103-12.
100. Sukhorukov GB, Donath E, Lichtenfeld H, et al. Layer-by-layerself assembly of polyelectrolytes on colloidal particles. ColloidsSurf A Physicochem Eng Asp 1998; 137: 253-66.
101. Menzel EJ, Farr C. Hyaluronidase and its substrate hyaluronan:biochemistry, biological activities and therapeutic uses. Cancer Lett 1998; 131: 3-11.
102. Slavkovsky R, Kohlerova R, Jiroutova A, et al. Effects of hyaluronan and iodine on wound contraction and granulation tissueformation in rat skin wounds. Clin Exp Dermatol 2010; 35(4): 373-9.
103. Aruffo A, Stamenkovic I, Melnick M, et al. CD44 is the principalcell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
104. Ogino S, Nishida N, Umemoto R, et al. Two-state conformations inthe hyaluronan-binding domain regulate CD44 adhesiveness underflow condition. Structure; 2010; 18: 649-56.
105. Marhaba R, Zoller M. CD44 in cancer progression: adhesion, migrationand growth regulation. J Mol Histol 2004; 35: 211-31.
106. Kuo YC, Su CH, Liu CY, et al. Transforming growth factor-betainduces CD44 cleavage that promotes migration of MDA-MB-435scells through the up-regulation of membrane type 1-matrix metalloproteinase. Int J Cancer 2009; 124: 2568-76.
107. Liu J, Jiang G. CD44 and hematologic malignancies. Cell MolImmunol 2006; 3: 359-65.
108. Midoux P, Breuzard G, Gomez JP, et al. Polymer-based gene delivery:a current review on the uptake and intracellular traffickingof polyplexes. Curr Gene Ther 2008; 8: 335-52.
109. Hornof M, de la Fuente M, Hallikainen M, et al. Low molecularweight hyaluronan shielding of DNA/PEI polyplexes facilitatesCD44 receptor mediated uptake in human corneal epithelial cells. JGene Med 2008; 10: 70-80.
110. Harraghy N, Gaussin A, Mermod N. Sustained transgene expressionusing MAR elements. Curr Gene Ther 2008; 8: 353-66.
111. Palazzoli F, Carnus E, Wells DJ, et al. Sustained transgene expressionusing non-viral enzymatic systems for stable chromosomal integration. Curr Gene Ther 2008; 8: 367-90.
112. Kim BS, Lebedeva OV, Koynov K, et al. Effect of dendrimer generationon the assembly and mechanical properties of DNA/phosphorus dendrimer multilayer microcapsules. Macromolecules 2006; 39: 5479-83.
113. Barteau B, Chevre R, Letrou-Bonneval E, et al. Physicochemicalparameters of non-viral vectors that govern transfection efficiency. Curr Gene Ther 2008; 8: 313-23.
114. Ai H, Jones SA, Lvov YM. Biomedical applications of electrostaticlayer-by-layer nano-assembly of polymers, enzymes, and nanoparticles. Cell Biochem Biophys 2003; 39: 23-43.
115. Elzbieciak M, Zapotoczny S, Nowak P, et al. Influence of pH onthe structure of multilayer films composed of strong and weakpolyelectrolytes. Langmuir 2009; 25: 3255-9.
116. Poptoshev E, Schoeler B, Caruso F. Influence of solvent quality onthe growth of polyelectrolyte multilayers. Langmuir 2004; 20: 829-34.
117. Steitz R, Leiner V, Siebrecht R, et al. Influence of the ionicstrength on the structure of polyelectrolyte films at the solid/liquidinterface. Colloids Surf A Physicochem Eng Asp 2000; 163: 63-70.
118. Ren K, Wang Y, Ji J, et al. Construction and deconstruction of PLL/DNA multilayered films for DNA delivery: effect of ionicstrength. Colloids Surf B Biointerfaces 2005; 46: 63-9.
119. Antipov AA, Sukhorukov GB, Mohwald H. Influence of the ionicstrength on the polyelectrolyte multilayers' permeability. Langmuir 2003; 19: 2444-8.
120. Vasir JK, Labhasetwar V. Biodegradable nanoparticles for cytosolicdelivery of therapeutics. Adv Drug Deliv Rev 2007; 59: 718-28.
121. Vasir JK, Labhasetwar V. Polymeric nanoparticles for gene delivery. Expert Opin Drug Deliv 2006; 3: 325-44.
122. Choksakulnimitr S, Masuda S, Tokuda H, et al. In vitro cytotoxicityof macromolecules in different cell culture systems. J Control Release 1995; 34: 233-41.
123. Daum N, Neumeyer A, Wahl B, et al. In vitro systems for studyingepithelial transport of macromolecules. Methods Mol Biol 2009; 480: 151-64.
124. Braun S. Muscular Gene transfer using nonviral vectors. Curr Gene Ther 2008; 8: 391-405.
125. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009; 109: 259-302.
126. Chen J, Huang SW, Lin WH, et al. Tunable film degradation and sustained release of plasmid DNA from cleavable polycation/plasmid DNA multilayers under reductive conditions. Small 2007; 3: 636-43.
127. Knorr V, Russ V, Allmendinger L, et al. Acetal linked oligoethyleniminesfor use as pH-sensitive gene carriers. Bioconjug Chem 2008; 19: 1625-34.
128. Werth S, Urban-Klein B, Dai L, et al. A low molecular weightfraction of polyethylenimine (PEI) displays increased transfectionefficiency of DNA and siRNA in fresh or lyophilized complexes. JControl Release 2006; 112: 257-70.
129. Perez C, Sanchez A, Putnam D, et al. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the deliveryof plasmid DNA. J Control Release 2001; 75: 211-24.
130. Maruyama A, Ishihara T, Kim JS, et al. Nanoparticle DNA carrierwith poly(L-lysine) grafted polysaccharide copolymer and poly(D, L-lactic acid). Bioconjug Chem 1997; 8: 735-42.
131. Kusonwiriyawong C, Atuah K, Alpar OH, et al. Cationic stearylamine-containing biodegradable microparticles for DNA delivery. J Microencapsul 2004; 21: 25-36.
132. Benoit MA, Ribet C, Distexhe J, et al. Studies on the potential of microparticles entrapping pDNA-poly(Aminoacids) complexes asvaccine delivery systems. J Drug Target 2001; 9: 253-66.
133. De Rosa G, Quaglia F, Bochot A, et al. Long-term release and improved intracellular penetration of oligonucleotidepolyethyleniminecomplexes entrapped in biodegradable microspheres. Biomacromolecules 2003; 4: 529-36.
134. Remaut K, Sanders NN, De Geest BG, et al. Nucleic acid delivery:Where material sciences and bio-sciences meet. Mater Sci Eng RRep 2007; 58: 117-61.
135. Lynn DM, Langer R. Degradable Poly(β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 2000; 122: 10761-8.
136. Akinc A, Anderson DG, Lynn DM, et al. Synthesis of poly(betaaminoester)s optimized for highly effective gene delivery. Bioconjug Chem 2003; 14: 979-88.
137. Little SR, Lynn DM, Ge Q, et al. Poly-beta amino ester-containingmicroparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci U S A 2004; 101: 9534-9.
138. Fredin NJ, Zhang J, Lynn DM. Nanometer-scale decomposition of ultrathin multilayered polyelectrolyte films. Langmuir 2007; 23: 2273-6.
139. Liu XH, Zhang JT, Lynn DM. Ultrathin multilayered films thatpromote the release of two DNA constructs with separate and distinctrelease profiles. Adv Mater 2008; 20: 4148-4153.
140. Zhang J, Fredin NJ, Janz JF, et al. Structure/property relationshipsin erodible multilayered films: influence of polycation structure onerosion profiles and the release of anionic polyelectrolytes. Langmuir 2006; 22: 239-45.
141. Agarwal A, Saraf S, Asthana A, et al. Ligand based dendritic systemsfor tumor targeting. Int J Pharm 2008; 350: 3-13.
142. Schmaljohann D. Thermo-and pH-responsive polymers in drugdelivery. Adv Drug Deliv Rev 2006; 58: 1655-70.
143. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector forgene and oligonucleotide transfer into cells in culture and in vivo:polyethylenimine. Proc Natl Acad Sci U S A 1995; 92: 7297-301.
144. Benns JM, Choi JS, Mahato RI, et al. pH-sensitive cationic polymergene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(Llysine)comb shaped polymer. Bioconjug Chem 2000; 11: 637-45.
145. Haensler J, Szoka FC, Jr. Polyamidoamine cascade polymers mediateefficient transfection of cells in culture. Bioconjug Chem 1993; 4: 372-9.
146. Antipov AA, Sukhorukov GB, Leporatti S, et al. Polyelectrolytemultilayer capsule permeability control. Colloids Surf A Physicochem Eng Asp 2002; 198-200: 535-41.
147. Grigsby CL, Leong KW. Balancing protection and release of DNA:tools to address a bottleneck of non-viral gene delivery. J R Soc Interface; 7 (Suppl 1): S67-82.
148. Blacklock J, Handa H, Soundara Manickam D, et al. Disassemblyof layer-by-layer films of plasmid DNA and reducible TAT polypeptide. Biomaterials 2007; 28: 117-24.
149. Zelikin AN, Li Q, Caruso F. Degradable polyelectrolyte capsulesfilled with oligonucleotide sequences. Angew Chem Int Ed Engl 2006; 45: 7743-5.
150. Borden MA, Caskey CF, Little E, et al. DNA and polylysine adsorptionand multilayer construction onto cationic lipid-coated microbubbles. Langmuir 2007; 23: 9401-8.
151. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles fordrug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001; 47: 113-31.
152. Waku T, Matsusaki M, Kaneko T, et al. PEG brush peptide nanosphereswith stealth properties and chemical functionality. Macromolecules 2007; 40: 6385-92.
153. Ogris M, Brunner S, Schuller S, et al. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extendedcirculation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595-605.
154. Oupicky D, Konak C, Dash PR, et al. Effect of albumin and polyanionon the structure of DNA complexes with polycation containinghydrophilic nonionic block. Bioconjug Chem 1999; 10: 764-72.
155. Zaitsev S, Cartier R, Vyborov O, et al. Polyelectrolyte nanoparticlesmediate vascular gene delivery. Pharm Res 2004; 21: 1656-61.
156. Chollet P, Favrot MC, Hurbin A, et al. Side-effects of a systemicinjection of linear polyethylenimine-DNA complexes. J Gene Med 2002; 4: 84-91.
157. Khopade AJ, Caruso F. Surface-modification of polyelectrolytemultilayer-coated particles for biological applications. Langmuir 2003; 19: 6219-25.
158. Ochs CJ, Such GK, Stadler B, et al. Low-fouling, biofunctionalized, and biodegradable click capsules. Biomacromolecules 2008; 9: 3389-96.
159. Wattendorf U, Kreft O, Textor M, et al. Stable stealth function forhollow polyelectrolyte microcapsules through a poly(ethylene glycol)grafted polyelectrolyte adlayer. Biomacromolecules 2008; 9: 100-8.
160. Philipp A, Meyer M, Wagner E. Extracellular targeting of synthetictherapeutic nucleic acid formulations. Curr Gene Ther 2008; 8: 324-34.
161. Fischlechner M, Zschornig O, Hofmann J, et al. Engineering virusfunctionalities on colloidal polyelectrolyte lipid composites. Angew Chem Int Ed Engl 2005; 44: 2892-5.
162. Cortez C, Tomaskovic-Crook E, Johnston APR, et al. Targetingand uptake of multilayered particles to colorectal cancer cells. Adv Mater 2006; 18: 1998-2003.
163. Zhang F, Wu Q, Chen ZC, et al. Bioactive galactose-branchedpolyelectrolyte multilayers and microcapsules: self-assembly, characterization, and biospecific lectin adsorption. Langmuir 2006; 22: 8458-64.
164. Zhang F, Wu Q, Chen ZC, et al. Hepatic-targeting microcapsulesconstruction by self-assembly of bioactive galactose-branchedpolyelectrolyte for controlled drug release system. J Colloid Interface Sci 2008; 317: 477-84.
165. Park JS, Na K, Woo DG, et al. Non-viral gene delivery of DNApolyplexed with nanoparticles transfected into human mesenchymalstem cells. Biomaterials 2010; 31: 124-32.
166. Harris TJ, Green JJ, Fung PW, et al. Tissue-specific gene deliveryvia nanoparticle coating. Biomaterials; 31: 998-1006.
167. Kogure K, Akita H, Yamada Y, et al. Multifunctional envelopetypenano device (MEND) as a non-viral gene delivery system. Adv Drug Deliv Rev 2008; 60: 559-71.
168. Akita H, Kudo A, Minoura A, et al. Multi-layered nanoparticles forpenetrating the endosome and nuclear membrane via a step-wisemembrane fusion process. Biomaterials 2009; 30: 2940-9.
169. Hu Y, Li K, Wang L, et al. Pegylated immuno-lipopolyplexes: Anovel non-viral gene delivery system for liver cancer therapy. JControl Release 2010; 144: 75-81.
170. Ke JH, Young TH. Multilayered polyplexes with the endosomalbuffering polycation in the core and the cell uptake-favorable polycationin the outer layer for enhanced gene delivery. Biomaterials 2010; 31: 9366-72.
171. Schneider G, Decher G. Functional core/shell nanoparticles vialayer-by-layer assembly. investigation of the experimental parametersfor controlling particle aggregation and for enhancing dispersionstability. Langmuir 2008; 24: 1778-89.
172. Wang Y, Angelatos AS, Caruso F. Template synthesis of nanostructuredmaterials via layer-by-layer assembly. Chem Mater 2008; 20: 848-58.
173. Montier T, Benvegnu T, Jaffres PA, et al. Progress in cationiclipid-mediated gene transfection: a series of bio-inspired lipids asan example. Curr Gene Ther 2008; 8: 296-312.